AU8114091A - The class ii protein of the outer membrane of neisseria meningitidis having immunologic carrier and enhancement properties - Google Patents

The class ii protein of the outer membrane of neisseria meningitidis having immunologic carrier and enhancement properties

Info

Publication number
AU8114091A
AU8114091A AU81140/91A AU8114091A AU8114091A AU 8114091 A AU8114091 A AU 8114091A AU 81140/91 A AU81140/91 A AU 81140/91A AU 8114091 A AU8114091 A AU 8114091A AU 8114091 A AU8114091 A AU 8114091A
Authority
AU
Australia
Prior art keywords
protein
class
outer membrane
neisseria meningitidis
enhancement properties
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU81140/91A
Other languages
English (en)
Inventor
John J. Donnelly
Arthur Friedman
Margaret A. Liu
Allen I. Oliff
Joseph Y Tai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU8114091A publication Critical patent/AU8114091A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU81140/91A 1990-07-19 1991-07-18 The class ii protein of the outer membrane of neisseria meningitidis having immunologic carrier and enhancement properties Abandoned AU8114091A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US55520490A 1990-07-19 1990-07-19
US555204 1990-07-19
US63945791A 1991-01-10 1991-01-10
US639457 1996-04-29

Publications (1)

Publication Number Publication Date
AU8114091A true AU8114091A (en) 1992-01-23

Family

ID=27070823

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81140/91A Abandoned AU8114091A (en) 1990-07-19 1991-07-18 The class ii protein of the outer membrane of neisseria meningitidis having immunologic carrier and enhancement properties

Country Status (9)

Country Link
JP (1) JPH0656690A (fr)
KR (1) KR920002631A (fr)
AU (1) AU8114091A (fr)
CA (1) CA2047043A1 (fr)
FI (1) FI913473A (fr)
IL (1) IL98837A0 (fr)
MX (1) MX9100272A (fr)
NO (1) NO912822L (fr)
PT (1) PT98381A (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU780308B2 (en) * 1999-04-30 2005-03-17 J. Craig Venter Institute, Inc. Neisseria genomic sequences and methods of their use
GB0011108D0 (en) * 2000-05-08 2000-06-28 Microscience Ltd Virulence gene and protein and their use

Also Published As

Publication number Publication date
FI913473A (fi) 1992-01-20
KR920002631A (ko) 1992-02-28
IL98837A0 (en) 1992-07-15
FI913473A0 (fi) 1991-07-18
CA2047043A1 (fr) 1992-01-20
PT98381A (pt) 1992-05-29
NO912822L (no) 1992-01-20
JPH0656690A (ja) 1994-03-01
MX9100272A (es) 1992-02-28
NO912822D0 (no) 1991-07-18

Similar Documents

Publication Publication Date Title
EP0713530A4 (fr) Expression a haut niveau, purification et repliement des proteines porines du groupe b de membrane externe de neisseria meningitidis
EP2270046A3 (fr) Procédés et compositions pour le traitement des maladies associées à hémolyse
AU648128B2 (en) Surface-modified support membrane and process therefor
AU9113991A (en) Mutant orientable proteins and coated substrates
AU6363490A (en) Biologically degradable cover film and method of preparation the same
AU2377497A (en) Proteins involved in the synthesis and assembly of o-antigen in (pseudomonas aeruginosa)
AU6492190A (en) Raised superimposed toilet seat and securing clamp
AU8427091A (en) Gamma-carboxylase and methods of use
AU3749499A (en) Novel molecules of the bgckr-related protein family and uses thereof
AU3114295A (en) Methods of prognosing the course and degree of dementia in patients with beta-amyloid-related diseases
AU8114091A (en) The class ii protein of the outer membrane of neisseria meningitidis having immunologic carrier and enhancement properties
AU622056B2 (en) Heating of bearings and the like
AU8113691A (en) The class ii protein of the outer membrane of neisseria meningitidis having immunologic carrier and enhancement properties, and vaccines containing same
AU8113791A (en) The class ii protein of the outer membrane of neisseria meningitidis having immunologic carrier and enhancement properties
AU5772299A (en) Novel molecules of the tango-93-related protein family and uses thereof
AU3965799A (en) Novel molecules of the t125-related protein family and uses thereof
AU647559B2 (en) Pyrimidinyl- and triazinyl-salicylamides and their use and preparation
ZA915627B (en) The class ii protein of the outer membrane of neisseria meningitidis having immunologic carrier and enhancement properties,and vaccines containing same
AU8544591A (en) Antigens associated with polymyositis and with dermatomyositis
ZA915629B (en) Class ii protein of the outer membrane of neisseria meningitidis having immune enhancement properties
AU8416791A (en) Articles of bedding and the like
AU3326693A (en) Bifunctional antithrombotic molecules and antithrombotic polypeptides
AU4545299A (en) Novel molecules of the aip-related protein family and uses thereof
AU3050689A (en) 16-homo piperidino androstanes and their preparation
AU8582791A (en) Admixtures of 2-bromo-2-bromomethylglutaronitrile and n,4-dihydroxy-alpha-oxobenzene-ethanimidoyl chloride